Pantoprazol Dura (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazol Dura, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and adolescents.

GNH USA supplies Pantoprazol Dura as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Dura is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Erosive gastritis and duodenal ulcer disease: accelerates healing of mucosal lesions. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumours.

Pantoprazol Dura may cause a range of adverse reactions. Most are mild and resolve after continued therapy.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: loose stools without blood. - Nausea: occasional feeling of stomach upset. - Abdominal pain: mild cramping. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhoea. - Low magnesium levels: muscle cramps, irregular heartbeat. - Liver enzyme elevation: asymptomatic increase in transaminases. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash. - Fracture risk: potential reduction in bone mineral density with long‑term use.

When prescribing Pantoprazol Dura, clinicians should consider several safety aspects: - Assess renal function: adjust dose in severe renal impairment. - Evaluate hepatic status: use with caution in moderate to severe liver disease. - Monitor long‑term users: watch for vitamin B12 deficiency and bone health. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Pregnancy and lactation: weigh benefits against potential risks; use only if clearly needed. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazol Dura can affect the pharmacokinetics of several co‑administered medicines. Awareness of key interactions helps maintain therapeutic efficacy.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption due to higher gastric pH. - HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation. - Methotrexate: reduced renal clearance; check serum levels. - Digoxin: slight increase in serum concentration; observe for toxicity.